112 research outputs found
Inhibition of Neutrophil Recruitment Partially Explained by Impaired Mobilization from Bone Marrow and Reduced Chemokine Levels
Rapid activation of the innate immune system is critical for an efficient host
response to invading pathogens. However, the inflammatory reaction has to be
strictly controlled to minimize harmful immunopathology. A number of mediators
including the cytokine interleukin-27 (IL-27) appear to be responsible for
limitation and resolution of inflammation. Despite increasing knowledge of its
suppressive effects on T cells, the influence on neutrophils and macrophages
is poorly understood. To determine the role of IL-27 in innate immune
responses we analysed the effect of IL-27 in a T cell independent model of
zymosan-induced peritonitis. Early administration of recombinant IL-27
strongly reduced the number of neutrophils recruited to the peritoneal cavity
after zymosan application as well as the neutrophil frequency in the blood.
Simultaneously, IL-27 reduced the release of neutrophils from the bone marrow
upon inflammation. Although cytokine levels were not affected by IL-27
treatment, the levels of the chemokines KC, MCP-1 and MIP-1α in the peritoneal
fluid were strongly decreased. These findings demonstrate that IL-27 is able
to control mobilisation and recruitment of neutrophils into the peritoneal
cavity and identify a novel mechanism to limit inflammation caused by innate
immune cells
Facilitated Peptide Transport via the Mucosal Epithelium
A hallmark of autoimmunity is the breakdown of tolerance and generation of
effector responses against self-antigens. Re-establishment of tolerance in
autoimmune disorders was always the most desired treatment option; however,
despite many efforts, clinical trials have been largely unsuccessful. This
also applies to the generation of oral tolerance, which seems to be a default
response type of the mucosa-associated lymphoid tissues to harmless antigens.
In this study, we report improved efficacy of oral tolerance induction by
coupling antigen with the newly identified mucosal carrier peptide 13C.
Antigen coupled to 13C is efficiently taken up in the gastrointestinal tract
and could be visualized in cells of the lamina propria. Oral, rectal, or nasal
treatment effectively induced the proliferation of antigen-specific T cells
with some increase in the frequency of regulatory T cells. In a model of
delayed-type hypersensitivity, especially intrarectal tolerization treatment
resulted in reduced footpad swelling, demonstrating a moderate tolerogenic
effect of mucosal treatment with 13C coupled antigen. Coupling of antigens to
a transmucosal carrier, therefore, is a promising tool to improve the efficacy
of vaccination via mucosal surfaces
The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4(+)CD25(+ )T cells
It is now generally accepted that CD4(+)CD25(+ )T(reg )cells play a major role in the prevention of autoimmunity and pathological immune responses. Their involvement in the pathogenesis of chronic arthritis is controversial, however, and so we examined their role in experimental antigen-induced arthritis in mice. Depletion of CD25-expressing cells in immunized animals before arthritis induction led to increased cellular and humoral immune responses to the inducing antigen (methylated bovine serum albumin; mBSA) and autoantigens, and to an exacerbation of arthritis, as indicated by clinical (knee joint swelling) and histological scores. Transfer of CD4(+)CD25(+ )cells into immunized mice at the time of induction of antigen-induced arthritis decreased the severity of disease but was not able to cure established arthritis. No significant changes in mBSA-specific immune responses were detected. In vivo migration studies showed a preferential accumulation of CD4(+)CD25(+ )cells in the inflamed joint as compared with CD4(+)CD25(- )cells. These data imply a significant role for CD4(+)CD25(+ )T(reg )cells in the control of chronic arthritis. However, transferred T(reg )cells appear to be unable to counteract established acute or chronic inflammation. This is of considerable importance for the timing of T(reg )cell transfer in potential therapeutic applications
Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells
Expression of the chemokines MCP-1/CCL2 and RANTES/CCL5 is differentially regulated by infiltrating inflammatory cells.BackgroundChemokines are involved in the regulation of the cellular renal infiltrate in glomerulonephritis; however, it is unclear to which degree resident glomerular cells or infiltrating leukocytes contribute to the formation of chemokines in glomerular inflammatory lesions. We therefore examined whether monocytes/macrophages play a role in the expression of the C-C chemokines MCP-1/CCL2 and RANTES/CCL5 in renal tissue in a lipopolysaccharide (LPS)-induced model of inflammation, where previously we have shown increased glomerular RANTES expression and glomerular infiltration of ED-1-positive cells.MethodsInflammatory lesions were induced by an intraperitoneal injection of LPS. The infiltration of monocytes into the glomerulus was reduced by two experimental approaches. First, rats were depleted of monocytes by the use of specific monocyte-antisera or by cytotoxic drugs. Second, the infiltration of monocytes into the kidney was reduced by using intercellular adhesion molecule-1 (ICAM-1) knockout mice.ResultsBoth experimental approaches demonstrated a significant reduction in the number of infiltrating monocytes/macrophages after lipopolysaccharide injection. This reduction in the infiltration of inflammatory cells was associated with significantly reduced RANTES/CCL5 mRNA expression. However, MCP-1/CCL2 mRNA expression was not inhibited after the LPS injection by monocyte/macrophage depletion. Also, the increase in nuclear factor-κB (NF-κB) binding activity after the LPS injection was not reduced in pretreated animals. The experiments therefore demonstrate that infiltrating monocytes/macrophages contribute to increased RANTES/CCL5 mRNA expression in inflammatory renal lesions, whereas MCP-1/CCL2 mRNA expression and NF-κB activation were not reduced by monocyte/macrophage depletion.ConclusionMCP-1/CCL2 released from renal tissue upon stimulation plays a major role in the regulation of monocyte/macrophage infiltration, which contributes significantly to increased renal RANTES/CCL5 expression. This cross-talk between resident renal cells and monocytes/macrophages is therefore likely to boost the number of infiltrating inflammatory cells
Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease
The scurfy mutant mouse strain suffers from a fatal lymphoproliferative disease leading to early death within 3–4 wk of age. A frame-shift mutation of the forkhead box transcription factor Foxp3 has been identified as the molecular cause of this multiorgan autoimmune disease. Foxp3 is a central control element in the development and function of regulatory T cells (T reg cells), which are necessary for the maintenance of self-tolerance. However, it is unclear whether dysfunction or a lack of T reg cells is etiologically involved in scurfy pathogenesis and its human correlate, the IPEX syndrome. We describe the generation of bacterial artificial chromosome–transgenic mice termed “depletion of regulatory T cell” (DEREG) mice expressing a diphtheria toxin (DT) receptor–enhanced green fluorescent protein fusion protein under the control of the foxp3 gene locus, allowing selective and efficient depletion of Foxp3+ T reg cells by DT injection. Ablation of Foxp3+ T reg cells in newborn DEREG mice led to the development of scurfy-like symptoms with splenomegaly, lymphadenopathy, insulitis, and severe skin inflammation. Thus, these data provide experimental evidence that the absence of Foxp3+ T reg cells is indeed sufficient to induce a scurfy-like phenotype. Furthermore, DEREG mice will allow a more precise definition of the function of Foxp3+ T reg cells in immune reactions in vivo
Enhanced Antitumor Immunity in Mice Deficient in CD69
We investigated the in vivo role of CD69 by analyzing the susceptibility of CD69−/− mice to tumors. CD69−/− mice challenged with MHC class I− tumors (RMA-S and RM-1) showed greatly reduced tumor growth and prolonged survival compared with wild-type (WT) mice. The enhanced anti–tumor response was NK cell and T lymphocyte–mediated, and was due, at least in part, to an increase in local lymphocytes. Resistance of CD69−/− mice to MHC class I− tumor growth was also associated with increased production of the chemokine MCP-1, diminished TGF-β production, and decreased lymphocyte apoptosis. Moreover, the in vivo blockade of TGF-β in WT mice resulted in enhanced anti–tumor response. In addition, CD69 engagement induced NK and T cell production of TGF-β, directly linking CD69 signaling to TGF-β regulation. Furthermore, anti-CD69 antibody treatment in WT mice induced a specific down-regulation in CD69 expression that resulted in augmented anti–tumor response. These data unmask a novel role for CD69 as a negative regulator of anti–tumor responses and show the possibility of a novel approach for the therapy of tumors
- …